Cerebral small vessel disease and silent cerebrovascular diseases: Modern standards of diagnosis, prevention, treatment prospects

dc.contributor.author	Esin R.
dc.contributor.author	Khairullin I.
dc.contributor.author	Abrarova G.
dc.contributor.author	Esin O.
dc.date.accessioned	2020-01-15T22:01:15Z
dc.date.available	2020-01-15T22:01:15Z
dc.date.issued	2019
dc.identifier.issn	1997-7298
dc.identifier.uri	https://dspace.kpfu.ru/xmlui/handle/net/156506
dc.description.abstract	© 2019, Media Sphera Publishing Group. All rights reserved. The review presents modern clinical and radiological criteria for cerebral small vessel disease and silent cerebrovascular diseases. The authors discuss the STRIVE criteria, ideas about the pathogenesis, morphological changes and proposed options for the prevention of disease progression. As a drug of choice, the authors recommend vinpocetine (cavinton), which has the ability to influence many parts of the pathogenesis of cerebral small vessel disease.
dc.relation.ispartofseries	Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova
dc.subject	Cerebrovascular diseases
dc.subject	Diagnosis
dc.subject	Small vessel disease
dc.subject	Vinpocetine
dc.title	Cerebral small vessel disease and silent cerebrovascular diseases: Modern standards of diagnosis, prevention, treatment prospects
dc.type	Review
dc.relation.ispartofseries-issue	4
dc.relation.ispartofseries-volume	119
dc.collection	Публикации сотрудников КФУ
dc.relation.startpage	81
dc.source.id	SCOPUS19977298-2019-119-4-SID85067123509

Файлы в этом документе

Размер: 56.66Kb

Формат: PDF

Публикации сотрудников КФУ Scopus [24551]
Коллекция содержит публикации сотрудников Казанского федерального (до 2010 года Казанского государственного) университета, проиндексированные в БД Scopus, начиная с 1970г.